|
|
 |
|
Viewing report
|
|
|
|
Forest Laboratories Inc.: PharmaVitae Profile
Datamonitor, Dec 2010, Pages: 67
Introduction
This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs
Features and benefits
- Gain insight into Forest's strategic outlook across the next 6 years
- Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Highlights
Strategic insight into the prospects for Forest over the next six years.
Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered
- Benchmark Forest's performance against key rivals in the prescription pharmaceutical sector
- Assess the effects of the patent expiry of Lexapro on the company
- See how the launch of the pipeline products, will generate new growth for the company
|
|
|
|
